PT2503338E - Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias - Google Patents

Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias Download PDF

Info

Publication number
PT2503338E
PT2503338E PT12002502T PT12002502T PT2503338E PT 2503338 E PT2503338 E PT 2503338E PT 12002502 T PT12002502 T PT 12002502T PT 12002502 T PT12002502 T PT 12002502T PT 2503338 E PT2503338 E PT 2503338E
Authority
PT
Portugal
Prior art keywords
therapies
evaluating
effectiveness
disease development
monitoring disease
Prior art date
Application number
PT12002502T
Other languages
English (en)
Portuguese (pt)
Inventor
Sirpa Jalkanen
Marko Salmi
Markku Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Publication of PT2503338E publication Critical patent/PT2503338E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PT12002502T 2007-10-24 2008-10-15 Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias PT2503338E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Publications (1)

Publication Number Publication Date
PT2503338E true PT2503338E (pt) 2015-03-05

Family

ID=38656804

Family Applications (2)

Application Number Title Priority Date Filing Date
PT12002502T PT2503338E (pt) 2007-10-24 2008-10-15 Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias
PT08842581T PT2201376E (pt) 2007-10-24 2008-10-15 Um novo biomarcador para monitorizar o desenvolvimento de doenças e avaliar a eficácia de tratamentos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT08842581T PT2201376E (pt) 2007-10-24 2008-10-15 Um novo biomarcador para monitorizar o desenvolvimento de doenças e avaliar a eficácia de tratamentos

Country Status (14)

Country Link
US (1) US20100209942A1 (https=)
EP (2) EP2201376B1 (https=)
JP (2) JP4982610B2 (https=)
KR (2) KR20100059902A (https=)
CA (1) CA2702635A1 (https=)
CY (2) CY1113403T1 (https=)
DK (2) DK2201376T3 (https=)
ES (2) ES2389751T3 (https=)
FI (1) FI20070795A0 (https=)
HR (2) HRP20120743T1 (https=)
PL (2) PL2201376T3 (https=)
PT (2) PT2503338E (https=)
SI (2) SI2503338T1 (https=)
WO (1) WO2009053523A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
AU2011281012A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting cardiovascular diseases or conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
PL2956772T3 (pl) * 2013-02-14 2018-12-31 Faron Pharmaceuticals Oy Sposób określenia biomarkerów związanych z zespołem ostrej niewydolności oddechowej (ARDS), sposób monitorowania rozwoju i leczenia ARDS u pacjenta
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
AU2015349878A1 (en) 2014-11-21 2017-05-25 Bristol-Myers Squibb Company Antibodies against CD73 and uses thereof
JP6668345B2 (ja) 2014-11-21 2020-03-18 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 修飾された重鎖定常領域を含む抗体
GB201706747D0 (en) * 2017-04-27 2017-06-14 Queen Mary Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515965A (ja) * 1995-08-18 2002-05-28 ダブリュー． ランドリ，ドナルド 抗体触媒反応の調節による有機化合物の検出
EP0862652A1 (en) 1995-10-13 1998-09-09 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy
HUP0002003A3 (en) 2000-05-24 2003-01-28 Pronuk Biotechnologia Kft Process and reagent-kit for determining of 5'-nucleotidase activity
CA2439961A1 (en) * 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
WO2004079013A1 (en) * 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
FI20030467A0 (fi) * 2003-03-28 2003-03-28 Sirpa Jalkanen Menetelmä tulehdustilojen hoitamiseen
US7534423B2 (en) 2003-03-28 2009-05-19 Faron Pharmaceuticals Oy Method for inducing an elevated level of adenosine in an individual
CA2528152A1 (en) * 2003-06-03 2005-01-06 The Regents Of The University Of California Compositions and methods for treatment of disease with acetylated disaccharides
JP2009505658A (ja) * 2005-08-24 2009-02-12 ブリストル−マイヤーズ スクイブ カンパニー 上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
FI20051003A0 (fi) 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
EP2021350B1 (en) * 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
EP2041574B1 (en) * 2006-07-14 2016-11-16 The Regents of The University of California Cancer biomarkers and methods of use threof

Also Published As

Publication number Publication date
WO2009053523A1 (en) 2009-04-30
CA2702635A1 (en) 2009-04-30
ES2532361T3 (es) 2015-03-26
EP2201376B1 (en) 2012-08-08
EP2503338B1 (en) 2014-12-24
JP5619810B2 (ja) 2014-11-05
PL2201376T3 (pl) 2013-01-31
SI2503338T1 (sl) 2015-06-30
US20100209942A1 (en) 2010-08-19
HRP20120743T1 (hr) 2012-10-31
EP2201376A1 (en) 2010-06-30
JP2012159514A (ja) 2012-08-23
EP2201376A4 (en) 2011-03-23
FI20070795A0 (fi) 2007-10-24
DK2201376T3 (da) 2012-10-15
JP4982610B2 (ja) 2012-07-25
ES2389751T3 (es) 2012-10-31
CY1116089T1 (el) 2017-02-08
PL2503338T3 (pl) 2015-06-30
EP2503338A2 (en) 2012-09-26
JP2011501176A (ja) 2011-01-06
CY1113403T1 (el) 2016-06-22
KR20160029869A (ko) 2016-03-15
SI2201376T1 (sl) 2012-09-28
KR20100059902A (ko) 2010-06-04
DK2503338T3 (en) 2015-03-09
HRP20150181T1 (hr) 2015-06-19
EP2503338A3 (en) 2013-03-13
PT2201376E (pt) 2012-08-20

Similar Documents

Publication Publication Date Title
PT2503338E (pt) Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias
BRPI0812315A2 (pt) Arquitetura para sistemas de monitoramento de saúde
EP2014237A4 (en) ULTRASOUND DEVICE
ES2402426T8 (es) Sonda médica
BRPI0813262A2 (pt) Biomarcadores de destruição de articulação para terapia de doença inflamatória de articulação anti-il-17a
BRPI0920262A2 (pt) armadilha para percevejos de cama
BRPI0817310A2 (pt) Ensaio de monitoramento de fármaco
DOS2006000058S (es) Masticador para animales
BRPI0920850A2 (pt) novos compostos e sua utilização
DE602007002875D1 (de) Ultraschall-einspritzventil
DK2042480T3 (da) Aminoindan-derivat eller salt deraf
BRPI0906080A2 (pt) Metodos e sistema para avaliar a quantidade de óleo para fritura
EP2060233A4 (en) ULTRASOUND DEVICE
EP2115426A4 (en) MONITORING THE STRUCTURAL INTACTNESS OF COMPONENTS
BRPI0814074A2 (pt) Método para a fabricação de 4-isopropil-3-metilfenol e sua utilização
FI20065078L (fi) Laite rainan tarkkailemiseksi
BRPI0820421A2 (pt) Monitoração de vibradores independentes
ES1062353Y (es) Uña perfeccionada para flexometro
ES1061806Y (es) Cercado perfeccionado para cerramiento
ES1063735Y (es) Testero para persiana
ES1061108Y (es) Cercado perfeccionado para cerramiento
ES1063714Y (es) Dispositivo de acoplamiento para vallas
ES1063972Y (es) Pieza prefabricada para ejecucion de paramentos
ES1063412Y (es) Precerco para puertas
ES1061080Y (es) Piezas para construccion